Literature DB >> 20458619

Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late?

Henry Lik-Yuen Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20458619     DOI： 10.1007/s10620-010-1266-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  20 in total

Review 1.  Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?

Authors:  R J Fontana; A S Lok
Journal:  J Hepatol       Date:  2000-08       Impact factor: 25.083

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

Review 3.  EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Authors: 
Journal:  J Hepatol       Date:  2008-10-29       Impact factor: 25.083

4.  Prognostic factors in severe exacerbation of chronic hepatitis B.

Authors:  Man-Fung Yuen; Erwin Sablon; Chee-Kin Hui; Tak-Ming Li; He-Jun Yuan; Danny Ka-Ho Wong; Joke Doutreloigne; Veerle Bogaerts; Benjamin Chun-Yu Wong; Sheung-Tat Fan; Ching-Lung Lai
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

5.  Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection.

Authors:  S W Tsang; H L Chan; N W Leung; T N Chau; S T Lai; F K Chan; J J Sung
Journal:  Aliment Pharmacol Ther       Date:  2001-11       Impact factor: 8.171

6.  Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.

Authors:  Yao-Li Cui; Fang Yan; Yue-Bin Wang; Xue-Qin Song; Li Liu; Xue-Zhong Lei; Ming-Hua Zheng; Hong Tang; Ping Feng
Journal:  Dig Dis Sci       Date:  2010-05-29       Impact factor: 3.199

7.  Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.

Authors:  H L Tillmann; J Hadem; L Leifeld; K Zachou; A Canbay; C Eisenbach; I Graziadei; J Encke; H Schmidt; W Vogel; A Schneider; U Spengler; G Gerken; G N Dalekos; H Wedemeyer; M P Manns
Journal:  J Viral Hepat       Date:  2006-04       Impact factor: 3.728

8.  Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.

Authors:  Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Grace Lai-Hung Wong; Joseph Jao-Yao Sung; Henry Lik-Yuen Chan
Journal:  Liver Transpl       Date:  2007-09       Impact factor: 5.799

Review 9.  A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

Authors:  Emmet B Keeffe; Douglas T Dieterich; Steven-Huy B Han; Ira M Jacobson; Paul Martin; Eugene R Schiff; Hillel Tobias
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-23       Impact factor: 11.382

10.  High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.

Authors:  Henry Lik-Yuen Chan; Chi-Hang Tse; Frankie Mo; Jane Koh; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Stephen Lam Chan; Winnie Yeo; Joseph Jao-Yiu Sung; Tony Shu-Kam Mok
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544
View more
  4 in total

1.  Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Tianyan Chen; Yingli He; Xiaojing Liu; Zhi Yan; Ke Wang; Hongli Liu; Shuling Zhang; Yingren Zhao
Journal:  Clin Exp Med       Date:  2011-10-15       Impact factor: 3.984

2.  Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure.

Authors:  Ling Gao; Jie-Fei Wang; Ming Xiang; Yu-Chen Fan; Zheng-Guo Zhang; Kai Wang
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

3.  Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model.

Authors:  Ke Ma; Wei Guo; Meifang Han; Guang Chen; Tao Chen; Zenguang Wu; Daofeng Yang; Jiaquan Huang; Yuancheng Huang; Xiping Zhao; Deying Tian; Jianxin Song; Junying Qi; Qin Ning
Journal:  Hepatol Int       Date:  2012-02-25       Impact factor: 6.047

4.  Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure.

Authors:  En-Qiang Chen; Meng-Lan Wang; Dong-Mei Zhang; Ying Shi; Do-Bo Wu; Li-Bo Yan; Ling-Yao Du; Ling-Yun Zhou; Hong Tang
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.